In studies from a Tunisian population and a Northern Chinese population, SLE patients treated with glucocorticoids and hydroxychloroquine showed a higher percentage of CD4+IFNγ+ (Th1) cells as compared with that in healthy controls (1, 2). The gene discussed is CD4; the disease is systemic lupus erythematosus.